Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Revenue Breakdown and Options Chain

Gain deeper insights into company revenues with a detailed analysis of revenue sources.
Explore the updated Options feature, providing in-depth data, and a 3D viewing option.

Last Close
Apr 15 04:00PM ET
7.12
Dollar change
-0.02
Percentage change
-0.28
%
IndexRUT P/E- EPS (ttm)-3.28 Insider Own27.56% Shs Outstand56.68M Perf Week0.00%
Market Cap437.10M Forward P/E- EPS next Y-2.83 Insider Trans-0.07% Shs Float44.47M Perf Month-19.46%
Income-209.96M PEG- EPS next Q-0.77 Inst Own92.49% Short Float17.40% Perf Quarter-15.94%
Sales0.00M P/S- EPS this Y-2.04% Inst Trans-0.78% Short Ratio5.60 Perf Half Y-51.73%
Book/sh6.87 P/B1.04 EPS next Y7.40% ROA-34.66% Short Interest7.74M Perf Year-56.24%
Cash/sh7.60 P/C0.94 EPS next 5Y- ROE-41.29% 52W Range5.89 - 24.81 Perf YTD-15.54%
Dividend Est.- P/FCF- EPS past 5Y-37.07% ROI-42.55% 52W High-71.30% Beta1.22
Dividend TTM- Quick Ratio12.40 Sales past 5Y0.00% Gross Margin- 52W Low20.88% ATR (14)0.44
Dividend Ex-Date- Current Ratio12.40 EPS Y/Y TTM-12.40% Oper. Margin0.00% RSI (14)39.47 Volatility4.54% 5.86%
Employees284 Debt/Eq0.18 Sales Y/Y TTM- Profit Margin- Recom1.11 Target Price13.56
Option/ShortYes / Yes LT Debt/Eq0.17 EPS Q/Q-11.81% Payout- Rel Volume0.49 Prev Close7.14
Sales Surprise- EPS Surprise13.72% Sales Q/Q- EarningsFeb 08 BMO Avg Volume1.38M Price7.12
SMA20-7.56% SMA50-10.81% SMA200-45.45% Trades Volume671,857 Change-0.28%
Date Action Analyst Rating Change Price Target Change
Apr-17-23Resumed Piper Sandler Overweight $44
Nov-19-21Initiated Piper Sandler Overweight $52
Oct-15-21Resumed BTIG Research Buy $60
Nov-17-20Initiated BTIG Research Buy $60
Nov-02-20Initiated Jefferies Buy $67
Oct-15-20Upgrade H.C. Wainwright Neutral → Buy $25 → $54
Jul-01-20Downgrade H.C. Wainwright Buy → Neutral $25
May-05-20Initiated Barclays Overweight $21
Sep-04-19Initiated ROTH Capital Buy $20
Jul-23-19Initiated Chardan Capital Markets Buy $28
Apr-07-24 05:00PM
Apr-04-24 08:00AM
Mar-26-24 07:30AM
Mar-11-24 09:55AM
Mar-08-24 12:00PM
08:00AM Loading…
Mar-06-24 08:00AM
Mar-05-24 08:00AM
Feb-27-24 03:30AM
Feb-23-24 09:55AM
Feb-08-24 08:42AM
08:00AM
Jan-22-24 10:54AM
Jan-16-24 03:59AM
Dec-28-23 08:00AM
Dec-05-23 07:32AM
07:10AM Loading…
07:10AM
07:00AM
Nov-13-23 09:55AM
Nov-08-23 09:10AM
Nov-07-23 08:00AM
Nov-03-23 07:30PM
Oct-17-23 03:00AM
Sep-19-23 04:01PM
08:00AM
Sep-14-23 01:23PM
Aug-03-23 08:00AM
Aug-01-23 08:00AM
Jul-31-23 04:01PM
Jul-28-23 03:57PM
Jul-20-23 08:00AM
10:00AM Loading…
Jun-06-23 10:00AM
Jun-05-23 08:00AM
Jun-03-23 02:15PM
Jun-01-23 04:01PM
May-25-23 05:00PM
May-18-23 08:00AM
May-17-23 10:02AM
May-09-23 08:00AM
Mar-31-23 09:35AM
Mar-08-23 08:00AM
Feb-24-23 09:35AM
Feb-09-23 08:50AM
08:00AM
Feb-07-23 08:00AM
Jan-06-23 09:55AM
09:04AM
08:50AM
Jan-05-23 05:44AM
Jan-04-23 08:05AM
08:00AM
Jan-03-23 08:00AM
Dec-14-22 10:46AM
Dec-12-22 02:36PM
Dec-08-22 09:04PM
Dec-07-22 04:04PM
10:05AM
07:00AM
06:30AM
Nov-23-22 08:00AM
Nov-22-22 08:00AM
Nov-03-22 08:00AM
Nov-02-22 04:01PM
Oct-14-22 01:52PM
Oct-07-22 08:00AM
Aug-24-22 07:58AM
Aug-06-22 09:36AM
Aug-04-22 08:00AM
Aug-01-22 04:01PM
Jun-03-22 08:00AM
Jun-02-22 08:00AM
May-30-22 06:42AM
May-26-22 05:15PM
May-19-22 08:00AM
May-03-22 08:55AM
Apr-14-22 01:35PM
Mar-30-22 07:00AM
Mar-21-22 08:00AM
Feb-11-22 08:00AM
Feb-03-22 08:00AM
Jan-31-22 04:01PM
Jan-10-22 07:00AM
Jan-04-22 08:00AM
Dec-17-21 09:35AM
Dec-08-21 07:38PM
Dec-02-21 08:00AM
Nov-12-21 07:00AM
Nov-04-21 08:00AM
Nov-01-21 08:00AM
Oct-01-21 08:01AM
Aug-09-21 09:52AM
Aug-06-21 08:00AM
Aug-02-21 08:00AM
Jul-07-21 08:00AM
Jun-03-21 07:00AM
May-20-21 08:00AM
May-10-21 08:00AM
May-05-21 07:00AM
Apr-28-21 08:00AM
Apr-21-21 08:00AM
Apr-12-21 04:01PM
Replimune Group, Inc. is a clinical-stage biotechnology company. It engages in the business of developing oncolytic immunotherapies for the treatment of cancer. The company was founded by Philip Astley-Sparke, Colin A. Love, and Robert Coffin in March 2015 and is headquartered in Woburn, MA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Xynos KonstantinosChief Medical OfficerNov 16 '23Sale10.927,31379,858112,714Nov 17 08:01 PM
Sarchi ChristopherChief Commercial OfficerNov 16 '23Sale10.925,25557,38572,245Nov 17 08:00 PM
Esposito PamelaChief Business OfficerSep 12 '23Option Exercise3.30300990263,736Sep 13 09:02 PM
Esposito PamelaChief Business OfficerSep 12 '23Sale20.003006,000263,436Sep 13 09:02 PM
Esposito PamelaChief Business OfficerSep 11 '23Option Exercise3.305,35817,681268,794Sep 13 09:02 PM
Esposito PamelaChief Business OfficerSep 11 '23Sale20.015,358107,214263,436Sep 13 09:02 PM
Esposito PamelaChief Business OfficerAug 22 '23Option Exercise6.5818,600122,380282,036Aug 24 08:30 PM
Esposito PamelaChief Business OfficerAug 22 '23Sale20.0118,600372,186263,436Aug 24 08:30 PM
Esposito PamelaChief Business OfficerAug 11 '23Option Exercise3.301,4004,620264,836Aug 15 08:30 PM
Esposito PamelaChief Business OfficerAug 11 '23Sale20.001,40028,000263,436Aug 15 08:30 PM
Esposito PamelaChief Business OfficerJul 10 '23Option Exercise6.3520,000127,000283,436Jul 11 09:00 PM
Esposito PamelaChief Business OfficerJul 10 '23Sale21.5820,000431,541263,436Jul 11 09:00 PM
Lewis TanyaChief Dev. Op. OfficerJun 13 '23Sale24.0612,860309,395135,293Jun 15 09:01 PM
Patel SushilChief Strategy OfficerJun 13 '23Sale24.045,698137,008148,873Jun 15 09:00 PM
Astley-Sparke PhilipChief Executive OfficerMay 16 '23Sale18.0517,902323,1311,525,278May 18 08:30 PM
Patel SushilChief Strategy OfficerMay 16 '23Sale18.0515,575281,129154,571May 18 08:36 PM
Lewis TanyaChief Dev. Op. OfficerMay 16 '23Sale18.0512,207220,336148,153May 18 08:34 PM
Franchi Jean M.Chief Financial OfficerMay 16 '23Sale18.0511,351204,886128,748May 18 08:32 PM
Love ColinChief Operating OfficerMay 16 '23Sale18.0510,775194,489794,960May 18 08:33 PM
Coffin RobertPresident & Chief R&D OfficerMay 16 '23Sale18.057,861141,8911,833,336May 18 08:35 PM
Esposito PamelaChief Business OfficerMay 16 '23Sale18.055,966107,686263,436May 18 08:31 PM
Xynos KonstantinosChief Medical OfficerMay 16 '23Sale18.0577113,917120,027May 18 08:31 PM